Endo International | ENDP - Ebitda



Ebitda تغيير تاريخ
AbbVie USD 5.37B 1.85B 2025-12
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Coherus Biosciences USD -43.33M 4.7M 2025-09
Eli Lilly USD 12.14B 4.26B 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Hikma Pharmaceutical USD 369M 84M 2024-12
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Novartis USD 5.3B 530M 2026-03
Pacira USD 40.24M 1.53M 2026-03
Perrigo USD 141.6M 1.34B 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Phibro Animal Health USD 68.1M 6.2M 2025-12
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
Takeda JPY 150.25B 297.88B 2026-03
Teva Pharmaceutical Industries USD 1.06B 582M 2026-03
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12
Zoetis USD 939M 101M 2025-12